Neural Tracing Protein‐Functionalized Nanoparticles Capable of Fast Retrograde Axonal Transport in Live Neurons

Author:

Wang Wenqian1ORCID,Hassan Md. Musfizur1,Kapoor‐Kaushik Natasha2,Livni Lital3,Musrie Benjamin3,Tang Jianbo1ORCID,Mahmud Zaheri1,Lai Saluo1,Wich Peter Richard1ORCID,Ananthanarayanan Vaishnavi4,Moalem‐Taylor Gila3ORCID,Mao Guangzhao1ORCID

Affiliation:

1. School of Chemical Engineering University of New South Wales (UNSW Sydney) Sydney NSW 2052 Australia

2. Electron Microscopy Unit University of New South Wales (UNSW) Sydney NSW 2052 Australia

3. School of Biomedical Sciences University of New South Wales (UNSW) Sydney NSW 2052 Australia

4. EMBL Australia Node in Single Molecule Science Department of Molecular Medicine School of Biomedical Sciences University of New South Wales (UNSW) Sydney NSW 2052 Australia

Abstract

AbstractNeural tracing proteins like horseradish peroxidase‐conjugated wheat germ agglutinin (WGA‐HRP) can target the central nervous system (CNS) through anatomic retrograde transport without crossing the blood–brain barrier (BBB). Conjugating WGA‐HRP to nanoparticles may enable the creation of BBB‐bypassing nanomedicine. Microfluidics and two‐photon confocal microscopy is applied to screen nanocarriers for transport efficacy and gain mechanistic insights into their interactions with neurons. Protein modification of gold nanoparticles alters their cellular uptake at the axonal terminal and activates fast retrograde transport. Trajectory analysis of individual endosomes carrying the nanoparticles reveals a run‐and‐pause pattern along the axon with endosomes carrying WGA‐HRP‐conjugated gold nanoparticles exhibiting longer run duration and faster instantaneous velocity than those carrying nonconjugated nanoparticles. The results offer a mechanistic explanation of the different axonal transport dynamics as well as a cell‐based functional assay of neuron‐targeted nanoparticles with the goal of developing BBB‐bypassing nanomedicine for the treatment of nervous system disorders.

Funder

Australian Research Council

National Institutes of Health

EMBL Australia

Multiple Sclerosis Australia

Publisher

Wiley

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3